Chairman Michael J. Farrell - 11 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
11 Nov 2021
Net transactions value
-$2,269,844
Form type
4
Filing time
15 Nov 2021, 12:18:15 UTC
Previous filing
04 Oct 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $2,269,844 -8,748 -2.1% $259.47 415,958 11 Nov 2021 Direct F1, F2
holding RMD ResMed Common Stock 8,970 11 Nov 2021 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted for dates 11/14/2018, 11/21/2019 and 11/19/2020.
F2 Includes 94.5633 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.